Target intelligence / Profile preview

N-methyl-D-aspartate receptor polyamine site (NMDAR polyamine site)

Target
NMDAR polyamine site
Molecular classification
Receptor, Ion channel, Ligand-gated ion channel
01

Overview

The polyamine binding site refers to specific regulatory regions on the N-methyl-D-aspartate (NMDA) receptor and inwardly rectifying potassium (Kir) channels that interact with endogenous polyamines such as spermine and spermidine [7, 8]. On the NMDA receptor, these sites act as allosteric modulators; at low concentrations, polyamines enhance receptor activity by increasing the affinity for glycine and the frequency of channel opening, while at higher concentrations, they can exert an inhibitory effect [10, 11]. In Kir channels, polyamines function as intracellular pore blockers, providing the molecular basis for inward rectification by obstructing the channel at depolarized membrane potentials [3, 15]. These sites are critical for regulating synaptic plasticity and neuronal excitability, and their dysregulation is implicated in neurodegenerative diseases, stroke, and chronic pain [1, 21]. Pharmacological agents targeting these sites, such as the antagonist arcaine or the NR2B-selective modulator ifenprodil, are investigated for their neuroprotective potential and ability to mitigate excitotoxicity [10, 11]. Additionally, the elevated polyamine levels observed in many cancers make these binding sites and the associated transport systems potential targets for oncological interventions [2, 13]. Recent research has also identified potential polyamine binding pockets in viral proteins like the SARS-CoV-2 ORF3a, suggesting a role in viral-host interactions [16].

Other names
Polyamine binding siteNMDA receptor polyamine siteSpermine binding siteSpermidine binding sitePolyamine regulatory siteKir channel polyamine block site
02

Mechanism of action

Allosteric modulation of NMDA receptor activity and voltage-dependent pore blockade of inwardly rectifying potassium channels.

03

Biological functions

Signal transductionSynaptic plasticityIon transportNeurotransmissionCell proliferationGene expression regulation
04

Disease associations

Neurodegenerative diseaseStrokeChronic painCancerEpilepsyDepression
05

Safety considerations

Psychotomimetic effectsCognitive impairmentMotor coordination deficitsExcitotoxicity risk
06

Interacting drugs

Spermine

7 more in the full profile.

07

Biomarkers

Cerebrospinal fluid polyamine levelsNMDA receptor subunit expression levelsIntracellular spermine/spermidine ratiosHypusinated eIF5A levels

Beyond the preview

Go deeper on N-methyl-D-aspartate receptor polyamine site (NMDAR polyamine site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methyl-D-aspartate receptor polyamine site (NMDAR polyamine site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call